147 related articles for article (PubMed ID: 25503645)
1. Identification of benzenesulfonamide quinoline derivatives as potent HIV-1 replication inhibitors targeting Rev protein.
Zhong F; Geng G; Chen B; Pan T; Li Q; Zhang H; Bai C
Org Biomol Chem; 2015 Feb; 13(6):1792-9. PubMed ID: 25503645
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of HIV-1 replication by targeting the Rev protein.
Nakaya T; Iwai S; Fujinaga K; Otsuka E; Ikuta K
Leukemia; 1997 Apr; 11 Suppl 3():134-7. PubMed ID: 9209321
[TBL] [Abstract][Full Text] [Related]
3. New HIV-1 replication inhibitors of the styryquinoline class bearing aroyl/acyl groups at the C-7 position: synthesis and biological activity.
Normand-Bayle M; Bénard C; Zouhiri F; Mouscadet JF; Leh H; Thomas CM; Mbemba G; Desmaële D; d'Angelo J
Bioorg Med Chem Lett; 2005 Sep; 15(18):4019-22. PubMed ID: 16002283
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis, and biological evaluation of novel quinoline derivatives as HIV-1 Tat-TAR interaction inhibitors.
Chen S; Chen R; He M; Pang R; Tan Z; Yang M
Bioorg Med Chem; 2009 Mar; 17(5):1948-56. PubMed ID: 19217787
[TBL] [Abstract][Full Text] [Related]
5. Potent inhibition of HIV-1 replication by backbone cyclic peptides bearing the Rev arginine rich motif.
Chaloin L; Smagulova F; Hariton-Gazal E; Briant L; Loyter A; Devaux C
J Biomed Sci; 2007 Sep; 14(5):565-84. PubMed ID: 17520355
[TBL] [Abstract][Full Text] [Related]
6. Heterocyclic compounds that inhibit Rev-RRE function and human immunodeficiency virus type 1 replication.
Shuck-Lee D; Chen FF; Willard R; Raman S; Ptak R; Hammarskjold ML; Rekosh D
Antimicrob Agents Chemother; 2008 Sep; 52(9):3169-79. PubMed ID: 18625767
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and biological properties of novel pyridinioalkanoyl thiolesters (PATE) as anti-HIV-1 agents that target the viral nucleocapsid protein zinc fingers.
Turpin JA; Song Y; Inman JK; Huang M; Wallqvist A; Maynard A; Covell DG; Rice WG; Appella E
J Med Chem; 1999 Jan; 42(1):67-86. PubMed ID: 9888834
[TBL] [Abstract][Full Text] [Related]
8. Inhibitors of HIV-1 gene expression and transcription.
Baba M
Curr Top Med Chem; 2004; 4(9):871-82. PubMed ID: 15134546
[TBL] [Abstract][Full Text] [Related]
9. Structure-based design of an RNA-binding p-terphenylene scaffold that inhibits HIV-1 Rev protein function.
González-Bulnes L; Ibáñez I; Bedoya LM; Beltrán M; Catalán S; Alcamí J; Fustero S; Gallego J
Angew Chem Int Ed Engl; 2013 Dec; 52(50):13405-9. PubMed ID: 24214163
[No Abstract] [Full Text] [Related]
10. Nuclear Factor 90, a cellular dsRNA binding protein inhibits the HIV Rev-export function.
Urcuqui-Inchima S; Castaño ME; Hernandez-Verdun D; St-Laurent G; Kumar A
Retrovirology; 2006 Nov; 3():83. PubMed ID: 17125513
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of HIV-1 Rev-RRE interaction by diphenylfuran derivatives.
Ratmeyer L; Zapp ML; Green MR; Vinayak R; Kumar A; Boykin DW; Wilson WD
Biochemistry; 1996 Oct; 35(42):13689-96. PubMed ID: 8885849
[TBL] [Abstract][Full Text] [Related]
12. Characterization of novel inhibitors of HIV-1 replication that function via alteration of viral RNA processing and rev function.
Wong RW; Balachandran A; Haaland M; Stoilov P; Cochrane A
Nucleic Acids Res; 2013 Nov; 41(20):9471-83. PubMed ID: 23945945
[TBL] [Abstract][Full Text] [Related]
13. Styrylquinoline derivatives: a new class of potent HIV-1 integrase inhibitors that block HIV-1 replication in CEM cells.
Mekouar K; Mouscadet JF; Desmaële D; Subra F; Leh H; Savouré D; Auclair C; d'Angelo J
J Med Chem; 1998 Jul; 41(15):2846-57. PubMed ID: 9667973
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, biological evaluation and molecular modeling of 4,6-diarylpyrimidines and diarylbenzenes as novel non-nucleosides HIV-1 reverse transcriptase inhibitors.
Ribone SR; Leen V; Madrid M; Dehaen W; Daelemans D; Pannecouque C; Briñón MC
Eur J Med Chem; 2012 Dec; 58():485-92. PubMed ID: 23159806
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of HIV-1 replication and infectivity by expression of a fusion protein, VPR-anti-integrase single-chain variable fragment (SFv): intravirion molecular therapies.
BouHamdan M; Kulkosky J; Duan LX; Pomerantz RJ
J Hum Virol; 2000; 3(1):6-15. PubMed ID: 10774802
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of acute-, latent-, and chronic-phase human immunodeficiency virus type 1 (HIV-1) replication by a bistriazoloacridone analog that selectively inhibits HIV-1 transcription.
Turpin JA; Buckheit RW; Derse D; Hollingshead M; Williamson K; Palamone C; Osterling MC; Hill SA; Graham L; Schaeffer CA; Bu M; Huang M; Cholody WM; Michejda CJ; Rice WG
Antimicrob Agents Chemother; 1998 Mar; 42(3):487-94. PubMed ID: 9517921
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and anti-HIV activity of alkylated quinoline 2,4-diols.
Ahmed N; Brahmbhatt KG; Sabde S; Mitra D; Singh IP; Bhutani KK
Bioorg Med Chem; 2010 Apr; 18(8):2872-9. PubMed ID: 20350812
[TBL] [Abstract][Full Text] [Related]
18. Rev-derived peptides inhibit HIV-1 replication by antagonism of Rev and a co-receptor, CXCR4.
Shimane K; Kodama EN; Nakase I; Futaki S; Sakurai Y; Sakagami Y; Li X; Hattori T; Sarafianos SG; Matsuoka M
Int J Biochem Cell Biol; 2010 Sep; 42(9):1482-8. PubMed ID: 20580677
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of nuclear import mediated by the Rev-arginine rich motif by RNA molecules.
Fineberg K; Fineberg T; Graessmann A; Luedtke NW; Tor Y; Lixin R; Jans DA; Loyter A
Biochemistry; 2003 Mar; 42(9):2625-33. PubMed ID: 12614157
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of C-2 and C-3 substituted quinolines and their evaluation as anti-HIV-1 agents.
Shah P; Naik D; Jariwala N; Bhadane D; Kumar S; Kulkarni S; Bhutani KK; Singh IP
Bioorg Chem; 2018 Oct; 80():591-601. PubMed ID: 30036815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
